文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
A. Kato
发表
A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
H. Eguchi, Y. Doki, M. Mori, 2022, AntiCancer Research.
Effect of subsequent chemotherapy on overall survival in first-line chemotherapy with targeted agents for patients with metastatic colorectal cancer: Systematic review and meta-analysis of randomized control trials.
Y. Doki, M. Mori, T. Mizushima, 2017 .